We are live on ! Find out more
OPRX icon

OptimizeRx

51 hedge funds and large institutions have $72.4M invested in OptimizeRx in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

4.35% less ownership

Funds ownership: 58.96%54.62% (-4.3%)

9% less funds holding

Funds holding: 5651 (-5)

16% less capital invested

Capital invested by funds: $85.8M → $72.4M (-$13.4M)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.5M

Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
18
Reduced
18
Closed
12
Calls
Puts
$1.5M
Net Calls
-$1.5M
Net Calls Change
-$1.39M

OPRX Hedge Fund Activity: Q1 2020 in Review

51 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2020, worth a combined $72.4M — down 16% from $85.8M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of OPRX and 8 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 18 added.

The largest buyer was G2 Investment Partners Management, adding an estimated $1.54M. The largest seller was Wolverine Asset Management, cutting an estimated $2.67M.

  • 51 institutional investors held OptimizeRx (OPRX) as of Q1 2020, down from 56 in Q4 2019.
  • Funds reported $72.4M of OptimizeRx stock for Q1 2020, down 16% quarter-over-quarter.
  • 8 funds opened new OptimizeRx positions in Q1 2020 and 12 closed out, a net change of -4 holders.
  • The largest OptimizeRx buyer in Q1 2020 was G2 Investment Partners Management, an estimated $1.54M added.
  • The largest OptimizeRx seller in Q1 2020 was Wolverine Asset Management, an estimated $2.67M sold.

Based on aggregated 13F filings for Q1 2020.